Viewing Study NCT02880956


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-04 @ 2:51 AM
Study NCT ID: NCT02880956
Status: COMPLETED
Last Update Posted: 2022-08-26
First Post: 2016-08-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01-26
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-30
Primary Completion Date Type: ACTUAL
Completion Date: 2021-07-28
Completion Date Type: ACTUAL
First Submit Date: 2016-08-24
First Submit QC Date: None
Study First Post Date: 2016-08-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-07-05
Results First Submit QC Date: None
Results First Post Date: 2022-08-26
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2022-08-26
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2022-08-04
Last Update Post Date: 2022-08-26
Last Update Post Date Type: ACTUAL